Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 122, Issue 3, Pages 333-339
Publisher
Springer Science and Business Media LLC
Online
2019-12-02
DOI
10.1038/s41416-019-0582-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Hereditary Pancreatic Cancer: A Retrospective Single-Center Study of 5143 Italian Families with History of BRCA-Related Malignancies
- (2019) Angela Toss et al. Cancers
- Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
- (2019) Talia Golan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms
- (2018) Maeve A Lowery et al. JNCI-Journal of the National Cancer Institute
- Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial
- (2018) Andrew Tutt et al. NATURE MEDICINE
- Prospective Evaluation of Germline Alterations in Patients With Exocrine Pancreatic Neoplasms
- (2018) Maeve A Lowery et al. JNCI-Journal of the National Cancer Institute
- Evaluating Susceptibility to Pancreatic Cancer: ASCO Clinical Practice Provisional Clinical Opinion Summary
- (2018) Elena M. Stoffel et al. Journal of Oncology Practice
- Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history
- (2017) Kari G Chaffee et al. GENETICS IN MEDICINE
- Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
- (2017) Dung T. Le et al. SCIENCE
- A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) initiative
- (2016) Michael J. Pishvaian et al. Oncotarget
- Identification of germline genetic mutations in patients with pancreatic cancer
- (2015) Erin E. Salo-Mullen et al. CANCER
- Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma
- (2015) Spring Holter et al. JOURNAL OF CLINICAL ONCOLOGY
- DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
- (2015) Joaquin Mateo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
- (2014) T Golan et al. BRITISH JOURNAL OF CANCER
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- (2014) L. Rahib et al. CANCER RESEARCH
- BRCA1, BRCA2, PALB2 and CDKN2A mutations in familial pancreatic cancer: a PACGENE study
- (2014) David B. Zhen et al. GENETICS IN MEDICINE
- Analysis of PALB2 Gene in BRCA1/BRCA2 Negative Spanish Hereditary Breast/Ovarian Cancer Families with Pancreatic Cancer Cases
- (2013) Ana Blanco et al. PLoS One
- Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer
- (2012) Kelly L. Bolton JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started